BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35708454)

  • 1. Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids.
    Yan CH; Hubbard CC; Lee TA; Sharp LK; Evans CT; Calip GS; Rowan SA; McGregor JC; Gellad WF; Suda KJ
    JDR Clin Trans Res; 2023 Oct; 8(4):402-412. PubMed ID: 35708454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Opioid Prescribing by Dentists in the United States and England.
    Suda KJ; Durkin MJ; Calip GS; Gellad WF; Kim H; Lockhart PB; Rowan SA; Thornhill MH
    JAMA Netw Open; 2019 May; 2(5):e194303. PubMed ID: 31125102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention's Opioid Prescribing Guidelines.
    Scherrer JF; Tucker J; Salas J; Zhang Z; Grucza R
    JAMA Netw Open; 2020 Dec; 3(12):e2027481. PubMed ID: 33263762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System.
    Northrup TF; Carroll K; Suchting R; Villarreal YR; Zare M; Stotts AL
    J Am Board Fam Med; 2019; 32(3):362-374. PubMed ID: 31068400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Rescheduling Hydrocodone on Opioid Prescribing in Ohio.
    Liu Y; Baker O; Schuur JD; Weiner SG
    Pain Med; 2020 Sep; 21(9):1863-1870. PubMed ID: 31502638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products.
    Bernhardt MB; Taylor RS; Hagan JL; Patel N; Chumpitazi CE; Fox KA; Glover C
    Am J Health Syst Pharm; 2017 Dec; 74(24):2046-2053. PubMed ID: 29222361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid prescribing by oral and maxillofacial surgeons in the United States, 2016-2019.
    Khouja T; Polk DE; Suda KJ
    J Public Health Dent; 2022 Sep; 82(4):491-494. PubMed ID: 36210548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provider specialty and odds of a new codeine, hydrocodone, oxycodone and tramadol prescription before and after the CDC opioid prescribing guideline publication.
    Tucker J; Salas J; Zhang Z; Grucza R; Scherrer JF
    Prev Med; 2021 May; 146():106466. PubMed ID: 33636196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone.
    Haynes A; Kleinschmidt K; Forrester MB; Young A
    Clin Toxicol (Phila); 2016 Jun; 54(5):434-40. PubMed ID: 26919555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Hydrocodone Schedule Change With Opioid Prescriptions Following Surgery.
    Habbouche J; Lee J; Steiger R; Dupree JM; Khalsa C; Englesbe M; Brummett C; Waljee J
    JAMA Surg; 2018 Dec; 153(12):1111-1119. PubMed ID: 30140896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis of the impact of Michigan's opioid prescribing legislation on discharge opioid prescribing at a single institution.
    Sadowski R; Hillaker E; Chavarria M; Khaliq F; Schwark A
    J Opioid Manag; 2022; 18(5):467-474. PubMed ID: 36226786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Hydrocodone Misuse Exposures Reported to U.S. Poison Centers Following Rescheduling in 2014.
    Fischer LJ; Severtson SG; Gurrola MC; Iwanicki JL; Green JL; Dart RC
    Subst Use Misuse; 2022; 57(7):1097-1103. PubMed ID: 35450512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a more strict 2014 DEA schedule designation for hydrocodone products on opioid prescription rates in the United States.
    Harrison ML; Walsh TL
    Clin Toxicol (Phila); 2019 Nov; 57(11):1064-1072. PubMed ID: 30789065
    [No Abstract]   [Full Text] [Related]  

  • 14. Patterns in opioid prescription in the United States by region and prescribers over a 4-year period.
    Bigal LM; Bibeau K; Dumbar S
    J Opioid Manag; 2019; 15(6):499-506. PubMed ID: 31850512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center.
    Schultz S; Chamberlain C; Vulcan M; Rana H; Patel B; Alexander JC
    J Opioid Manag; 2016; 12(2):119-22. PubMed ID: 27194196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling.
    Wu A; Phan C; Nguyen KC; Quindoy M; Lewis J; Apollonio DE
    Clin Toxicol (Phila); 2021 Apr; 59(4):313-319. PubMed ID: 32840386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures.
    Mallama C; Karami S; Zhang D; Zhao Y; Yang Y; Woods C; Ding Y; Meyer T; McAninch J
    Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5793. PubMed ID: 38783553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Opioid Prescribing Guidelines on Prescriptions by Emergency Physicians in Ohio.
    Weiner SG; Baker O; Poon SJ; Rodgers AF; Garner C; Nelson LS; Schuur JD
    Ann Emerg Med; 2017 Dec; 70(6):799-808.e1. PubMed ID: 28549620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Opioid Prescribing in a Pediatric Emergency Department After the Rescheduling of Hydrocodone.
    Chumpitazi CE; Rees CA; Camp EA; Bernhardt MB
    J Emerg Med; 2017 Apr; 52(4):547-553. PubMed ID: 27727038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.